KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 20 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $8,388,000 | +3.6% | 9,900,000 | 0.0% | 0.22% | +5.8% |
Q4 2021 | $8,093,000 | +53.6% | 9,900,000 | +41.4% | 0.21% | +37.1% |
Q3 2021 | $5,268,000 | -25.0% | 7,000,000 | 0.0% | 0.15% | -23.4% |
Q2 2021 | $7,021,000 | +65.2% | 7,000,000 | +70.7% | 0.20% | +28.8% |
Q1 2021 | $4,249,000 | -17.7% | 4,100,000 | 0.0% | 0.15% | -15.5% |
Q4 2020 | $5,164,000 | +5.3% | 4,100,000 | 0.0% | 0.18% | +1.7% |
Q3 2020 | $4,902,000 | -14.7% | 4,100,000 | 0.0% | 0.18% | -30.5% |
Q2 2020 | $5,746,000 | -2.2% | 4,100,000 | 0.0% | 0.26% | +29.9% |
Q1 2020 | $5,876,000 | -31.5% | 4,100,000 | -31.7% | 0.20% | +35.9% |
Q4 2019 | $8,576,000 | – | 6,000,000 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birch Grove Capital LP | 9,000,000 | $6,561,000 | 2.60% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 31,050,000 | $22,600,000 | 0.52% |
Context Capital Management, LLC | 7,000 | $5,079,000 | 0.36% |
DeepCurrents Investment Group LLC | 11,890,000 | $8,569,000 | 0.34% |
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 25,000,000 | $18,139,000 | 0.31% |
CAPSTONE INVESTMENT ADVISORS, LLC | 5,500,000 | $4,046,000 | 0.02% |
LAZARD ASSET MANAGEMENT LLC | 17,500,000 | $12,872,000 | 0.02% |
BLB&B Advisors, LLC | 100,000 | $73,000 | 0.01% |
MACKAY SHIELDS LLC | 221,000 | $163,000 | 0.00% |
JPMORGAN CHASE & CO | 900,000 | $655,000 | 0.00% |